17:45:49 EDT Mon 29 May 2023
Enter Symbol
or Name
USA
CA



MCI Onehealth Technologies Inc
Symbol DRDR
Shares Issued 50,075,202
Close 2022-11-07 C$ 1.00
Recent Sedar Documents

MCI Onehealth to releaes Q3 results Nov. 14

2022-11-07 17:40 ET - News Release

Mr. Nolan Reeds reports

MCI ONEHEALTH ANNOUNCES DATE OF ITS THIRD QUARTER 2022 EARNINGS CALL

MCI Onehealth Technologies Inc. will release its financial results for the three months ended Sept. 30, 2022, on Monday, Nov. 14, 2022, after the close of market.

MCI will host a conference call and webcast on the same day at 5:30 pm (ET) to discuss the financial results and progress towards its key strategic initiatives. The call will be hosted by Dr. Alexander Dobranowski, Chief Executive Officer and Scott Nirenberski, Chief Financial Officer.

MCI encourages attendees to join by webcast.

For attendees who wish to join by webcast, the event can be accessed at: https://edge.media-server.com/mmc/p/g77sxigc

Attendees who wish to join by phone must visit the following link and pre-register: https://register.vevent.com/register/BI22415b36e452414588260f7cdbc9a940

About MCI

MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada's leading primary care networks with more than 280 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via mciconnect.ca . MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company's current roadmap. For more information, visit mcionehealth.com.

We seek Safe Harbor.

© 2023 Canjex Publishing Ltd. All rights reserved.